Oxford Immunotec Global PLC (NASDAQ:OXFD)

13.27
Delayed Data
As of Mar 30
 +0.03 / +0.23%
Today’s Change
10.01
Today|||52-Week Range
21.25
-2.57%
Year-to-Date

Today’s Trading

Previous close13.24
Today’s open13.29
Day’s range13.15 - 14.28
Volume20,560
Average volume (3 months)85,503
Market cap$298.0M
Dividend yield--
Data as of 4:00pm ET, 03/30/2015

Growth & Valuation

Earnings growth (last year)+43.36%
Earnings growth (this year)-2.88%
Earnings growth (next 5 years)--
Revenue growth (last year)+27.64%
P/E ratio--
Price/Sales4.76
Price/Book3.85

Competitors

 Today’s
change
Today’s
% change
CALACalithera Bioscience...-1.03-5.90%
QTNTQuotient Ltd+0.62+4.03%
TTHITransition Therapeut...-0.03-0.44%
TROVTrovagene Inc0.000.00%
Data as of 3:59pm ET, 03/30/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$49.5M
Annual profit (last year)-$22.2M
Net profit margin-44.79%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Peter James Wrighton-Smith
Chief Operations Officer
Peter Edwardson
Corporate headquarters
Abingdon, Oxfordshire

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account